IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!) to follow this author

Dana P. Goldman

This is information that was supplied by Dana Goldman in registering through RePEc. If you are Dana P. Goldman, you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name:Dana
Middle Name:P.
Last Name:Goldman
Suffix:
RePEc Short-ID:pgo681
[This author has chosen not to make the email address public]
http://healthpolicy.usc.edu
Los Angeles, California (United States)
http://healthpolicy.usc.edu/

: 213-821-7940
213-821-3460
635 Downey Way, Unit 210, Los Angeles, CA 90089-3333
RePEc:edi:chuscus (more details at EDIRC)
Los Angeles, California (United States)
http://www.usc.edu/hsc/pharmacy/pharmecon/

: 323-442-1460
323-442-1462
1540 E Alcazar Street CHP 140, Los Angeles CA 90033
RePEc:edi:dpuscus (more details at EDIRC)
Los Angeles, California (United States)
https://dornsife.usc.edu/econ/

: (213) 740-8335
(213) 740-8543
KAP 300, University Park Campus, Los Angeles, CA-90089
RePEc:edi:deuscus (more details at EDIRC)
in new window
  1. David Powell & Dana Goldman, 2016. "Disentangling Moral Hazard and Adverse Selection in Private Health Insurance," NBER Working Papers 21858, National Bureau of Economic Research, Inc.
  2. Alice Chen & Dana Goldman, 2015. "Health Care Spending: Historical Trends and New Directions," NBER Working Papers 21501, National Bureau of Economic Research, Inc.
  3. Mariana Carrera & Dana Goldman & Geoffrey Joyce, 2013. "Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician," NBER Working Papers 19186, National Bureau of Economic Research, Inc.
  4. Powell, David & Goldman, Dana P., 2013. "Moral Hazard and Adverse Selection in Private Health Insurance," Working Papers 1032, RAND Corporation.
  5. Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zhen & Adam H. Gailey, 2011. "The Value of Medican and Pharmaceutical Interventions for Reducing Obesity," Cahiers de recherche 1109, CIRPEE.
  6. Lu, Yang & Goldman, Dana, 2010. "The Effects of Relative Food Prices on Obesity – Evidence from China: 1991-2006," Working Papers 58249, American Association of Wine Economists.
  7. Tomas J. Philipson & Gary Becker & Dana Goldman & Kevin M. Murphy, 2010. "Terminal Care and The Value of Life Near Its End," NBER Working Papers 15649, National Bureau of Economic Research, Inc.
  8. Pierre-Carl Michaud & Darius Lakdawalla & Dana Goldman & Neeraj Sood & Ze Cong, 2010. "Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data," Cahiers de recherche 1038, CIRPEE.
  9. Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
  10. Tomas J. Philipson & Eric C. Sun & Dana Goldman, 2009. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Working Papers 15603, National Bureau of Economic Research, Inc.
  11. Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H., 2009. "International Differences in Longevity and Health and Their Economic Consequences," IZA Discussion Papers 4367, Institute for the Study of Labor (IZA).
  12. Dana Goldman & Darius Lakdawalla & Yuhui Zheng, 2009. "Food Prices and the Dynamics of Body Weight," NBER Working Papers 15096, National Bureau of Economic Research, Inc.
  13. Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zheng & Adam Gailey, 2009. "Understanding the Economic Consequences of Shifting Trends in Population Health," NBER Working Papers 15231, National Bureau of Economic Research, Inc.
  14. John A. Romley & Dana Goldman, 2008. "How Costly Is Hospital Quality? A Revealed-Preference Approach," NBER Working Papers 13730, National Bureau of Economic Research, Inc.
  15. Dana Goldman & John A. Romley, 2008. "Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand," NBER Working Papers 14619, National Bureau of Economic Research, Inc.
  16. Dana P. Goldman & Nicole Maestas, 2007. "Medical Expenditure Risk and Household Portfolio Choice," Working Papers 325-1, RAND Corporation.
  17. Dana Goldman & Tomas Philipson, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," NBER Working Papers 12870, National Bureau of Economic Research, Inc.
  18. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.
  19. Baoping Shang & Dana P. Goldman, 2007. "Prescription Drug Coverage and Elderly Medicare Spending," NBER Working Papers 13358, National Bureau of Economic Research, Inc.
  20. Nicole Maestas & Mathis Schroeder & Dana P. Goldman, 2006. "Price Variation in Markets with Homogeneous Goods: The Case of Medigap," Working Papers 504, RAND Corporation.
  21. Dana Goldman & James P. Smith, 2005. "Socioeconomic Differences in the Adoption of New Medical Technologies," NBER Working Papers 11218, National Bureau of Economic Research, Inc.
  22. Dana Goldman & Neeraj Sood & Arleen Leibowitz, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance Costs," NBER Working Papers 11063, National Bureau of Economic Research, Inc.
  23. Dana P. Goldman & James P. Smith, 2004. "Can Patient Self-Management Help Explain the SES Health Gradient?," HEW 0403004, EconWPA.
  24. Dana Goldman & Darius Lakdawalla & Neeraj Sood, 2004. "HIV Breakthroughs and Risk Sexual Behavior," NBER Working Papers 10516, National Bureau of Economic Research, Inc.
  25. Goldman, Dana & Leibowitz, Arleen & Robalino, David, 2004. "Employee Responses to Health Insurance Premium Increases," MPRA Paper 12004, University Library of Munich, Germany.
  26. Dana P. Goldman & Neeraj Sood & Arleen Leibowitz, 2003. "The Reallocation of Compensation in Response to Health Insurance Premium Increases," NBER Working Papers 9540, National Bureau of Economic Research, Inc.
  27. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2003. "Market Evidence of Misperceived Prices and Mistaken Mortality Risks," NBER Working Papers 9863, National Bureau of Economic Research, Inc.
  28. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2002. "The Link Between Public and Private Insurance and HIV-Related Mortality," NBER Working Papers 9346, National Bureau of Economic Research, Inc.
  29. Dana Goldman & Darius Lakdawalla, 2001. "Understanding Health Disparities Across Education Groups," NBER Working Papers 8328, National Bureau of Economic Research, Inc.
  30. Darius Lakdawalla & Dana Goldman & Jay Bhattacharya, 2001. "Are the Young Becoming More Disabled?," NBER Working Papers 8247, National Bureau of Economic Research, Inc.
  1. Seabury Seth A. & Goldman Dana P. & Lakdawalla Darius N. & Gupta Charu N. & Khan Zeba M. & Chandra Amitabh & Philipson Tomas J., 2016. "Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection," Forum for Health Economics & Policy, De Gruyter, vol. 19(1), pages 141-156, June.
  2. Gaudette Étienne & Tysinger Bryan & Goldman Dana P. & Cassil Alwyn, 2015. "Health and Health Care of Medicare Beneficiaries in 2030," Forum for Health Economics & Policy, De Gruyter, vol. 18(2), pages 75-96, December.
  3. Étienne Gaudette & Dana Goldman & Andrew Messali & Neeraj Sood, 2015. "Do Statins Reduce the Health and Health Care Costs of Obesity?," PharmacoEconomics, Springer, vol. 33(7), pages 723-734, July.
  4. Seabury Seth A. & Lakdawalla Darius N. & Goldman Dana P. & Walter Deborah & Hayes John & Gustafson Thomas & Shrestha Anshu, 2014. "Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants," Forum for Health Economics & Policy, De Gruyter, vol. 17(2), pages 1-16, September.
  5. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 359-373, 03.
  6. Edlin Aaron & Goldman Dana P. & Leive Adam A., 2014. "The Future of US Health Care: Is Medicare Really Better at “Saving” Money?," The Economists' Voice, De Gruyter, vol. 11(1), pages 1-7, November.
  7. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Response To Epstein'S Comment On “Heterogeneity In Action”," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 376-378, 03.
  8. Dana P. Goldman & Peter R. Orszag, 2014. "The Growing Gap in Life Expectancy: Using the Future Elderly Model to Estimate Implications for Social Security and Medicare," American Economic Review, American Economic Association, vol. 104(5), pages 230-233, May.
  9. Goldman Dana P. & Leive Adam & Lakdawalla Darius, 2013. "Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall," The Economists' Voice, De Gruyter, vol. 10(1), pages 39-43, December.
  10. Joyce, Geoffrey F. & Zissimopoulos, Julie & Goldman, Dana P., 2013. "Digesting the doughnut hole," Journal of Health Economics, Elsevier, vol. 32(6), pages 1345-1355.
  11. Goldman Dana P. & Lakdawalla Darius & Sood Neeraj & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Agus David & Jena Anupam B. & Philipson Tomas J., 2013. "The Value of Diagnostic Testing in Personalized Medicine," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 121-133, September.
  12. Dana Goldman & Nicole Maestas, 2013. "Medical Expenditure Risk And Household Portfolio Choice," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 28(4), pages 527-550, 06.
  13. Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H., 2012. "The value of medical and pharmaceutical interventions for reducing obesity," Journal of Health Economics, Elsevier, vol. 31(4), pages 630-643.
  14. Philipson Tomas J. & Sun Eric & Goldman Dana & Jena Anupam B., 2012. "A Reexamination of the Costs of Medical R&D Regulation," Forum for Health Economics & Policy, De Gruyter, vol. 15(2), pages 1-28, October.
  15. Hackbarth, Andrew D. & Romley, John A. & Goldman, Dana P., 2011. "Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards," Social Science & Medicine, Elsevier, vol. 73(8), pages 1163-1168.
  16. Michaud, Pierre-Carl & Goldman, Dana & Lakdawalla, Darius & Gailey, Adam & Zheng, Yuhui, 2011. "Differences in health between Americans and Western Europeans: Effects on longevity and public finance," Social Science & Medicine, Elsevier, vol. 73(2), pages 254-263, July.
  17. Goldman, Dana & Smith, James P., 2011. "The increasing value of education to health," Social Science & Medicine, Elsevier, vol. 72(10), pages 1728-1737, May.
  18. Goldman Dana P & Zissimopoulos Julie & Lu Yang, 2011. "Medical Expenditure Measures in the Health and Retirement Study," Forum for Health Economics & Policy, De Gruyter, vol. 14(3), pages 1-33, April.
  19. John A. Romley & Dana P. Goldman, 2011. "How Costly is Hospital Quality? A Revealed‐Preference Approach," Journal of Industrial Economics, Wiley Blackwell, vol. 59(4), pages 578-608, December.
  20. Katherine Baicker & Dana Goldman, 2011. "Patient Cost-Sharing and Healthcare Spending Growth," Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 47-68, Spring.
  21. Dana P. Goldman & Geoffrey F. Joyce & William B. Vogt, 2011. "Part D Formulary and Benefit Design as a Risk-Steering Mechanism," American Economic Review, American Economic Association, vol. 101(3), pages 382-386, May.
  22. Tomas J. Philipson & Seth A. Seabury & Lee M. Lockwood & Dana P. Goldman & Darius N. Lakdawalla, 2010. "Geographic Variation in Health Care: The Role of Private Markets," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 41(1 (Spring), pages 325-361.
  23. Daniella Perlroth & Dana Goldman & Alan Garber, 2010. "The potential impact of comparative effectiveness research on U.S. Health Care expenditures," Demography, Springer;Population Association of America (PAA), vol. 47(1), pages 173-190, March.
  24. Baoping Shang & Dana Goldman, 2010. "Prescription Drug Coverage and Medicare Spending among U.S. Elderly*," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(4), pages 539-567, October.
  25. Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J., 2010. "An economic evaluation of the war on cancer," Journal of Health Economics, Elsevier, vol. 29(3), pages 333-346, May.
  26. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.
  27. Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana, 2010. "The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000," Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-22, February.
  28. Smith, James Patrick & Goldman, Dana, 2010. "Can patient self-management explain the health gradient? revisited: A response to Maitra," Social Science & Medicine, Elsevier, vol. 70(6), pages 813-815, March.
  29. Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin, 2010. "Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA," Health Economics, John Wiley & Sons, Ltd., vol. 19(12), pages 1510-1510, December.
  30. Goldman Dana P & Lakdawalla Darius N, 2010. "Can the ACA Improve Population Health?," The Economists' Voice, De Gruyter, vol. 7(5), pages 1-5, December.
  31. Goldman, Dana & Michaud, Pierre-Carl & Lakdawalla, Darius & Zheng, Yuhui & Gailey, Adam & Vaynman, Igor, 2010. "The Fiscal Consequences of Trends in Population Health," National Tax Journal, National Tax Association, vol. 63(2), pages 307-330, June.
  32. Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin, 2010. "Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1109-1116.
  33. Bhattacharya, Jay & Goldman, Dana & Sood, Neeraj, 2009. "Market evidence of misperceived mortality risk," Journal of Economic Behavior & Organization, Elsevier, vol. 72(1), pages 451-462, October.
  34. Goldman Dana P & McFadden Daniel L, 2008. "Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000," The Economists' Voice, De Gruyter, vol. 5(4), pages 1-4, July.
  35. Baoping Shang & Dana Goldman, 2008. "Does age or life expectancy better predict health care expenditures?," Health Economics, John Wiley & Sons, Ltd., vol. 17(4), pages 487-501.
  36. Tomas J. Philipson & Dana Goldman, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," American Economic Review, American Economic Association, vol. 97(2), pages 427-432, May.
  37. Goldman Dana P & Joyce Geoffrey & Karaca-Mandic Pinar & Sood Neeraj, 2006. "Adverse Selection in Retiree Prescription Drug Plans," Forum for Health Economics & Policy, De Gruyter, vol. 9(1), pages 1-25, December.
  38. Goldman Dana P & Cutler David M & Shang Baoping & Joyce Geoffrey F, 2006. "The Value of Elderly Disease Prevention," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-29, January.
  39. Darius Lakdawalla & Neeraj Sood & Dana Goldman, 2006. "HIV Breakthroughs and Risky Sexual Behavior," The Quarterly Journal of Economics, Oxford University Press, vol. 121(3), pages 1063-1102.
  40. Goldman Dana P & Sood Neeraj & Leibowitz Arleen, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-17, January.
  41. Goldman, Dana P. & Sood, Neeraj & Leibowitz, Arleen, 2005. "The reallocation of compensation in response to health insurance premium increases," Economics Letters, Elsevier, vol. 88(2), pages 147-151, August.
  42. Goldman Dana P & Lakdawalla Darius N., 2005. "A Theory of Health Disparities and Medical Technology," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 4(1), pages 1-32, September.
  43. Dana Goldman & James P. Smith, 2005. "Socioeconomic Differences in the Adoption of New Medical Technologies," American Economic Review, American Economic Association, vol. 95(2), pages 234-237, May.
  44. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2004. "Price Regulation in Secondary Insurance Markets," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 71(4), pages 643-675.
  45. Bhattacharya Jayanta & Cutler David M. & Goldman Dana P. & Hurd Michael D. & Joyce Geoffrey F. & Lakdawalla Darius N. & Panis Constantijn W. A. & Shang Baoping, 2004. "Disability Forecasts and Future Medicare Costs," Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-22, January.
    • Jayanta Bhattacharya & David M. Cutler & Dana P. Goldman & Michael D. Hurd & Geoffrey F. Joyce & Darius N. Lakdawalla & Constantijn W. A. Panis, 2004. "Disability Forecasts and Future Medicare Costs," NBER Chapters, in: Frontiers in Health Policy Research, Volume 7, pages 75-94 National Bureau of Economic Research, Inc.
  46. Bhattacharya, Jayanta & Goldman, Dana & Sood, Neeraj, 2003. "The link between public and private insurance and HIV-related mortality," Journal of Health Economics, Elsevier, vol. 22(6), pages 1105-1122, November.
  47. Goldman Dana P & Joyce Geoffrey F & Malkin Jesse Dylan, 2002. "The Costs of A Medicare Prescription Drug Benefit," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 2(1), pages 1-18, April.
  48. Goldman D. P. & Bhattacharya J. & McCaffrey D. F. & Duan N. & Leibowitz A. A. & Joyce G. F. & Morton S. C., 2001. "Effect of Insurance on Mortality in an HIV-Positive Population in Care," Journal of the American Statistical Association, American Statistical Association, vol. 96, pages 883-894, September.
  49. Barton H. Hamilton & Vivian Ho & Dana P. Goldman, 2000. "Queuing for Surgery: Is the U.S. or Canada Worse Off?," The Review of Economics and Statistics, MIT Press, vol. 82(2), pages 297-308, May.
  50. Goldman, Dana P. & Hosek, Susan D. & Dixon, Lloyd S. & Sloss, Elizabeth M., 1995. "The effects of benefit design and managed care on health care costs," Journal of Health Economics, Elsevier, vol. 14(4), pages 401-418, October.
  51. Dana P. Goldman, 1995. "Managed Care as a Public Cost-Containment Mechanism," RAND Journal of Economics, The RAND Corporation, vol. 26(2), pages 277-295, Summer.
  1. Armando Franco & Dana Goldman & Adam Leive & Daniel McFadden, 2017. "A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis," NBER Chapters, in: Measuring and Modeling Health Care Costs National Bureau of Economic Research, Inc.
  2. Dana Goldman & Darius Lakdawalla & Yuhui Zheng, 2011. "Food Prices and the Dynamics of Body Weight," NBER Chapters, in: Economic Aspects of Obesity, pages 65-90 National Bureau of Economic Research, Inc.
  3. Goldman, Dana & Lakdawalla, Darius, 2011. "Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products," Handbook of Health Economics, Elsevier.
  4. Tomas J. Philipson & Eric Sun & Dana Goldman, 2010. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Chapters, in: Regulation vs. Litigation: Perspectives from Economics and Law, pages 137-163 National Bureau of Economic Research, Inc.
  5. Michael E. Chernew & Dana Goldman & Feng Pan, 2009. "Disability and Spending Growth," NBER Chapters, in: Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly, pages 237-248 National Bureau of Economic Research, Inc.
  6. Dana P. Goldman & Geoffrey Joyce & Pinar Karaca-Mandic, 2006. "Adverse Selection in Retiree Prescription Drug Plans," NBER Chapters, in: Frontiers in Health Policy Research, Volume 9 National Bureau of Economic Research, Inc.
  7. Dana P. Goldman & Neeraj Sood & Arleen Leibowitz, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8 National Bureau of Economic Research, Inc.
  8. Jayanta Bhattacharya & David M. Cutler & Dana P. Goldman & Michael D. Hurd & Geoffrey F. Joyce & Darius N. Lakdawalla & Constantijn W. A. Panis, 2004. "Disability Forecasts and Future Medicare Costs," NBER Chapters, in: Frontiers in Health Policy Research, Volume 7, pages 75-94 National Bureau of Economic Research, Inc.
  1. David Cutler & Alan Garber & Dana Goldman & William Vogt, 2010. "Frontiers in Health Policy Research, volume 13," NBER Books, National Bureau of Economic Research, Inc, number cutl09-1, March.
  2. David Cutler & Alan Garber & Dana Goldman, 2009. "Frontiers in Health Policy Research, volume 12," NBER Books, National Bureau of Economic Research, Inc, number cutl08-2, March.
  3. David Cutler & Alan Garber & Dana Goldman, 2007. "Frontiers in Health Policy Research, Volume 10," NBER Books, National Bureau of Economic Research, Inc, number cutl07-1, March.
NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 31 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (26) 2001-06-22 2002-11-28 2003-03-10 2003-07-21 2004-03-22 2004-06-07 2005-02-01 2005-04-03 2005-12-09 2007-09-16 2008-01-12 2009-01-10 2009-02-07 2009-07-03 2009-08-16 2009-08-16 2009-08-22 2009-08-22 2009-09-26 2009-09-26 2009-12-19 2010-02-20 2010-10-02 2011-03-19 2015-09-05 2016-03-23. Author is listed
  2. NEP-IAS: Insurance Economics (9) 2003-03-10 2005-02-01 2005-12-09 2007-02-10 2007-09-02 2007-09-16 2008-06-07 2009-02-07 2016-03-23. Author is listed
  3. NEP-AGE: Economics of Ageing (5) 2009-08-16 2009-08-16 2009-08-22 2009-08-22 2009-09-26. Author is listed
  4. NEP-AGR: Agricultural Economics (3) 2009-07-03 2010-02-20 2010-03-28
  5. NEP-EDU: Education (2) 2004-03-22 2004-06-07
  6. NEP-INO: Innovation (2) 2005-04-03 2010-10-02
  7. NEP-LAB: Labour Economics (2) 2003-03-10 2005-02-01
  8. NEP-MIC: Microeconomics (2) 2007-09-02 2009-02-07
  9. NEP-TRA: Transition Economics (2) 2010-02-20 2010-03-28
  10. NEP-CNA: China (1) 2010-02-20
  11. NEP-COM: Industrial Competition (1) 2007-09-02
  12. NEP-DCM: Discrete Choice Models (1) 2008-01-12
  13. NEP-DEV: Development (1) 2004-03-22
  14. NEP-EXP: Experimental Economics (1) 2010-10-02
  15. NEP-HIS: Business, Economic & Financial History (1) 2015-09-05
  16. NEP-LAW: Law & Economics (1) 2007-02-24
For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Dana Goldman should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.